Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Korro Bio, Inc. (KRRO)
since 2019 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Korro Bio, Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1703647.
Total stock buying since 2019: $34,964,851.
Total stock sales since 2019: $19,766,713.
Total stock option exercises since 2019: $726,968.
Table 3. Detailed insider trading at Korro Bio, Inc. (KRRO) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2022-02-16 | Lebel Carl (Chief Development Officer) | Sale | 831 | 4.43 | 3,680 |
| 2022-02-15 | Mccubbin Quentin (Chief Manufacturing Officer) | Sale | 1,261 | 4.33 | 5,461 |
| 2022-02-15 | Arnold Wendy S (Chief People Officer) | Sale | 1,168 | 4.33 | 5,058 |
| 2022-02-15 | Loose Christopher R. (Chief Scientific Officer) | Sale | 863 | 4.33 | 3,737 |
| 2022-02-15 | Pfreundschuh Peter P. (Chief Financial Officer) | Sale | 1,347 | 4.33 | 5,833 |
| 2022-02-15 | Lebel Carl (Chief Development Officer) | Sale | 844 | 4.33 | 3,655 |
| 2022-02-14 | Mccubbin Quentin (Chief Manufacturing Officer) | Option Ex | 17,500 | .00 | 0 |
| 2022-02-14 | Arnold Wendy S (Chief People Officer) | Option Ex | 15,000 | .00 | 0 |
| 2022-02-14 | Loose Christopher R. (Chief Scientific Officer) | Option Ex | 15,000 | .00 | 0 |
| 2022-02-14 | Pfreundschuh Peter P. (Chief Financial Officer) | Option Ex | 15,000 | .00 | 0 |
| 2022-02-14 | Lebel Carl (Chief Development Officer) | Option Ex | 15,000 | .00 | 0 |
| 2022-01-18 | Lucchino David L. (President and CEO) | Option Ex | 6,905 | .61 | 4,212 |
| 2021-12-20 | Lucchino David L. (President and CEO) | Option Ex | 6,905 | .61 | 4,212 |
| 2021-11-02 | Lucchino David L. (President and CEO) | Option Ex | 6,905 | .61 | 4,212 |
| 2021-10-05 | Lucchino David L. (President and CEO) | Option Ex | 6,905 | .61 | 4,212 |
| 2021-09-03 | Lucchino David L. (President and CEO) | Option Ex | 6,905 | .61 | 4,212 |
| 2021-08-03 | Lucchino David L. (President and CEO) | Option Ex | 6,905 | .61 | 4,212 |
| 2021-07-01 | Lucchino David L. (President and CEO) | Option Ex | 6,905 | .61 | 4,212 |
| 2021-06-21 | Lucchino David L. (President and CEO) | Option Ex | 113,690 | .61 | 69,350 |
| 2021-03-25 | Marcus Joel S (Director) | Option Ex | 37,116 | 3.37 | 125,080 |
| 2021-03-01 | Lucchino David L. (President and CEO) | Sale | 9,416 | 50.11 | 471,864 |
| 2021-03-01 | Lucchino David L. (President and CEO) | Option Ex | 9,416 | .61 | 5,743 |
| 2021-02-08 | Lucchino David L. (President and CEO) | Sale | 16,554 | 55.00 | 910,470 |
| 2021-02-08 | Lucchino David L. (President and CEO) | Option Ex | 16,554 | .61 | 10,097 |
| 2021-02-03 | Loose Christopher R. (Chief Scientific Officer) | Sale | 2,000 | 47.19 | 94,380 |
| 2021-02-03 | Lucchino David L. (President and CEO) | Sale | 11,036 | 48.75 | 538,005 |
| 2021-02-03 | Lucchino David L. (President and CEO) | Option Ex | 11,036 | .61 | 6,731 |
| 2021-02-02 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 45.02 | 360,200 |
| 2021-02-02 | Lucchino David L. (President and CEO) | Sale | 5,518 | 46.65 | 257,431 |
| 2021-02-02 | Lucchino David L. (President and CEO) | Option Ex | 5,518 | .61 | 3,365 |
| 2021-02-01 | Lucchino David L. (President and CEO) | Sale | 33,102 | 43.11 | 1,427,060 |
| 2021-02-01 | Lucchino David L. (President and CEO) | Option Ex | 33,102 | .61 | 20,192 |
| 2021-01-27 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 42.50 | 340,000 |
| 2021-01-27 | Lucchino David L. (President and CEO) | Sale | 9,196 | 42.50 | 390,830 |
| 2021-01-27 | Lucchino David L. (President and CEO) | Option Ex | 9,196 | .61 | 5,609 |
| 2021-01-06 | Lucchino David L. (President and CEO) | Sale | 27,586 | 38.24 | 1,054,916 |
| 2021-01-06 | Lucchino David L. (President and CEO) | Option Ex | 27,586 | .61 | 16,827 |
| 2021-01-04 | Lucchino David L. (President and CEO) | Sale | 34,104 | 34.05 | 1,161,377 |
| 2021-01-04 | Lucchino David L. (President and CEO) | Option Ex | 18,390 | .61 | 11,217 |
| 2020-12-22 | Marcus Joel S (Director) | Sale | 20,000 | 33.29 | 665,780 |
| 2020-12-21 | Marcus Joel S (Director) | Sale | 10,000 | 30.35 | 303,520 |
| 2020-12-18 | Marcus Joel S (Director) | Sale | 19,700 | 36.06 | 710,480 |
| 2020-12-17 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 41.25 | 330,000 |
| 2020-12-17 | Lucchino David L. (President and CEO) | Sale | 1,120 | 42.64 | 47,755 |
| 2020-12-17 | Lucchino David L. (President and CEO) | Option Ex | 1,120 | .61 | 683 |
| 2020-12-16 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 38.94 | 311,480 |
| 2020-12-16 | Lucchino David L. (President and CEO) | Sale | 13,514 | 40.00 | 540,560 |
| 2020-12-16 | Lucchino David L. (President and CEO) | Option Ex | 13,514 | .61 | 8,243 |
| 2020-12-15 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 37.28 | 298,240 |
| 2020-12-15 | Lucchino David L. (President and CEO) | Sale | 13,514 | 38.51 | 520,356 |
| 2020-12-15 | Lucchino David L. (President and CEO) | Option Ex | 13,514 | .61 | 8,243 |
| 2020-12-14 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 35.00 | 280,000 |
| 2020-12-14 | Lucchino David L. (President and CEO) | Sale | 13,514 | 35.12 | 474,611 |
| 2020-12-14 | Lucchino David L. (President and CEO) | Option Ex | 13,514 | .61 | 8,243 |
| 2020-12-09 | Lucchino David L. (President and CEO) | Sale | 13,514 | 32.93 | 444,988 |
| 2020-12-09 | Lucchino David L. (President and CEO) | Option Ex | 13,514 | .61 | 8,243 |
| 2020-12-08 | Lucchino David L. (President and CEO) | Sale | 8,848 | 31.24 | 276,411 |
| 2020-12-08 | Lucchino David L. (President and CEO) | Option Ex | 8,848 | .61 | 5,397 |
| 2020-12-07 | Lucchino David L. (President and CEO) | Sale | 4,666 | 30.02 | 140,063 |
| 2020-12-07 | Lucchino David L. (President and CEO) | Option Ex | 4,666 | .61 | 2,846 |
| 2020-12-01 | Lucchino David L. (President and CEO) | Sale | 15,714 | 28.27 | 444,313 |
| 2020-11-09 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 24.00 | 192,000 |
| 2020-11-05 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 23.00 | 184,000 |
| 2020-11-02 | Lucchino David L. (President and CEO) | Sale | 15,714 | 21.05 | 330,701 |
| 2020-10-13 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 22.00 | 176,000 |
| 2020-10-08 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 21.12 | 168,960 |
| 2020-10-07 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 20.00 | 160,008 |
| 2020-10-06 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 19.46 | 155,680 |
| 2020-10-05 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 18.35 | 146,800 |
| 2020-10-02 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 18.92 | 151,360 |
| 2020-10-01 | Loose Christopher R. (Chief Scientific Officer) | Sale | 8,000 | 18.84 | 150,720 |
| 2020-10-01 | Lucchino David L. (President and CEO) | Sale | 15,716 | 19.29 | 303,161 |
| 2020-09-23 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 21.50 | 96,763 |
| 2020-09-09 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 19.08 | 85,878 |
| 2020-09-01 | Lucchino David L. (President and CEO) | Sale | 15,714 | 18.73 | 294,260 |
| 2020-08-19 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 22.97 | 103,351 |
| 2020-08-05 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 21.56 | 97,006 |
| 2020-08-03 | Lucchino David L. (President and CEO) | Sale | 15,714 | 21.63 | 339,830 |
| 2020-07-22 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 21.51 | 96,790 |
| 2020-07-20 | Marcus Joel S (Director) | Buy | 55,555 | 18.00 | 999,990 |
| 2020-07-08 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 22.58 | 101,592 |
| 2020-07-01 | Lucchino David L. (President and CEO) | Sale | 15,714 | 22.45 | 352,826 |
| 2020-06-24 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 22.80 | 102,586 |
| 2020-06-10 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 19.96 | 89,829 |
| 2020-06-03 | Mitrano Richard J. (VP Finance & Operations) | Option Ex | 3,481 | .34 | 1,183 |
| 2020-06-02 | Lucchino David L. (President and CEO) | Sale | 3,839 | 18.57 | 71,274 |
| 2020-06-01 | Lucchino David L. (President and CEO) | Sale | 11,875 | 17.91 | 212,657 |
| 2020-05-21 | Marcus Joel S (Director) | Sale | 5,000 | 18.81 | 94,055 |
| 2020-05-20 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 19.07 | 85,824 |
| 2020-05-20 | Marcus Joel S (Director) | Sale | 5,000 | 18.76 | 93,795 |
| 2020-05-19 | Marcus Joel S (Director) | Sale | 7,809 | 18.40 | 143,669 |
| 2020-05-18 | Marcus Joel S (Director) | Sale | 15,000 | 19.15 | 287,190 |
| 2020-05-08 | Lucchino David L. (President and CEO) | Sale | 10,478 | 18.18 | 190,490 |
| 2020-05-06 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 16.45 | 74,038 |
| 2020-05-05 | Lucchino David L. (President and CEO) | Sale | 5,239 | 16.19 | 84,835 |
| 2020-05-01 | Lucchino David L. (President and CEO) | Sale | 5,236 | 15.28 | 79,995 |
| 2020-04-24 | Lucchino David L. (President and CEO) | Sale | 729 | 16.35 | 11,919 |
| 2020-04-23 | Lucchino David L. (President and CEO) | Sale | 1,410 | 16.08 | 22,674 |
| 2020-04-22 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 14.84 | 66,793 |
| 2020-04-17 | Lucchino David L. (President and CEO) | Sale | 3,100 | 16.00 | 49,600 |
| 2020-04-15 | Lucchino David L. (President and CEO) | Sale | 5,236 | 15.13 | 79,236 |
| 2020-04-08 | Loose Christopher R. (Chief Scientific Officer) | Sale | 4,500 | 14.99 | 67,468 |
| 2020-01-30 | Cohen Marc A (Director) | Option Ex | 88,116 | 2.27 | 199,670 |
| 2019-12-30 | Lucchino David L. (President and CEO) | Option Ex | 57,377 | .61 | 34,999 |
| 2019-10-07 | Mitrano Richard J. (VP Finance & Operations) | Buy | 107 | 14.00 | 1,498 |
| 2019-10-07 | Deerfield Partners, L.p. | Buy | 285,714 | 14.00 | 3,999,996 |
| 2019-10-07 | Cohen Marc A (Director) | Buy | 17,857 | 14.00 | 249,998 |
Insider trading activities including stock purchases, stock sales, and option exercises
of KRRO listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Korro Bio, Inc. (symbol KRRO,
CIK number 1703647) see
the Securities and Exchange Commission (SEC) website.